Mechanistic studies of rot-mediated regulation of Staphylococcus aureus virulence

腐烂介导的金黄色葡萄球菌毒力调节机制研究

基本信息

项目摘要

DESCRIPTION (provided by applicant): Staphylococcus aureus is one of the leading causes of life-threatening bacterial infections in both hospitals and community settings. This bacterium can colonize and invade virtually all tissues in the human body. The tremendous success of S. aureus as a pathogen is in part due to the temporal expression of an arsenal of virulence factors, which is executed by a series of two component regulatory systems (TCS) and helix-turn-helix proteins. Genetic analyses have revealed that at the center of the regulation of virulence factors in S. aureus are the transcription factors repressor of toxins (Rot) and the S. aureus exoprotein expression two-component system (SaeRS-TCS). Experiments using a murine model of systemic infection have revealed that S. aureus strains lacking rot are hypervirulent, while strains lacking sae are fully attenuated, highlighting the importance of these regulators for S. aureus pathophysiology. Rot is hypothesized to coordinate the differential expression of virulence factors by repressing the promoters of genes that code for cytotoxins and proteases, and activating the promoters of genes that code for surface proteins. In contrast, the SaeRS-TCS is involved in the activation of the promoters that code for most secreted factors, including cytotoxins. Comparison of the Rot and SaeRS regulons in clinically relevant strains has revealed that a large portion of Rot-repressed genes require the SaeRS-TCS for their activation. The precise molecular mechanism by which Rot regulates gene expression in S. aureus is not understood. Similarly, the mechanism by which Rot interferes with the SaeRS-TCS to alter the expression of target genes remains to be elucidated. Additionally, studies examining transcriptional and translational regulation of rot have primarily been done in vitro and do not necessarily mimic the impact this transcription factor has on virulence factor regulation in vivo. Thus, the Specific Aims of this proposal seek to: (i) define the mechanism of Rot-mediated regulation of virulence factors, and (ii) elucidate the regulation of rot transcriptio and translation ex vivo and in vivo. To accomplish these Aims, a multi-disciplinary approach will be employed where molecular biology, biochemistry, and bacteriology techniques will be combined with in vivo and ex vivo infection models. Collectively, the work proposed in this application will shed light into how Rot regulates the expression of virulence factors required for S. aureus pathogenesis. Due to the current epidemic of antibiotic-resistant S. aureus strains, understanding the intricacies of how S. aureus regulates the expression of virulence factors is likely to provide the foundation for the development of new anti-Staphylococcal drugs based on targeting regulatory circuits that are required for the pathogenesis of this bacterium.
描述(由申请人提供):金黄色葡萄球菌是医院和社区环境中危及生命的细菌感染的主要原因之一。这种细菌可以在人体的几乎所有组织中定居并侵入。金黄色葡萄球菌作为病原体的巨大成功部分是由于毒力因子库的时间表达,这是由一系列双组分调节系统(TCS)和螺旋-螺旋-螺旋蛋白执行的。遗传分析表明,金黄色葡萄球菌毒力因子调控的核心是毒素转录因子抑制因子(Rot)和金黄色葡萄球菌外蛋白表达双组分系统(SaeRS-TCS)。使用小鼠全身感染模型的实验表明,缺乏腐病的金黄色葡萄球菌菌株是高毒力的,而缺乏腐病的菌株是完全减毒的,突出了它们的重要性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Victor J. Torres其他文献

How do we manage post-OLT redundant bile duct?
我们如何管理 OLT 后多余胆管?
  • DOI:
    10.3748/wjg.v19.i16.2501
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Victor J. Torres;Nicholas Martinez;Gabriel H. Lee;J. Almeda;G. Gross;Sandeep N. Patel;L. Rosenkranz
  • 通讯作者:
    L. Rosenkranz
SARS-CoV-2 infection predisposes patients to coinfection with emStaphylococcus aureus/em
严重急性呼吸综合征冠状病毒 2 型感染使患者易并发金黄色葡萄球菌感染
  • DOI:
    10.1128/mbio.01667-24
  • 发表时间:
    2024-07-26
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Ashira Lubkin;Lucie Bernard-Raichon;Ashley L. DuMont;Ana Mayela Valero Jimenez;Gregory G. Putzel;Juan Gago;Erin E. Zwack;Olufolakemi Olusanya;Kristina M. Boguslawski;Simone Dallari;Sophie Dyzenhaus;Christin Herrmann;Juliana K. Ilmain;Georgia L. Isom;Miranda Pawline;Andrew I. Perault;Sofya Perelman;William E. Sause;Ifrah Shahi;Amelia St. John;Victor J. Torres
  • 通讯作者:
    Victor J. Torres
The two-component system WalKR provides an essential link between cell wall homeostasis and DNA replication in emStaphylococcus aureus/em
双组分系统 WalKR 在金黄色葡萄球菌中提供了细胞壁稳态与 DNA 复制之间的重要联系
  • DOI:
    10.1128/mbio.02262-23
  • 发表时间:
    2023-11-10
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Liam K. R. Sharkey;Romain Guerillot;Calum J. Walsh;Adrianna M. Turner;Jean Y. H. Lee;Stephanie L. Neville;Stephan Klatt;Sarah L. Baines;Sacha J. Pidot;Fernando J. Rossello;Torsten Seemann;Hamish E. G. McWilliam;Ellie Cho;Glen P. Carter;Benjamin P. Howden;Christopher A. McDevitt;Abderrahman Hachani;Timothy P. Stinear;Ian R. Monk;Victor J. Torres
  • 通讯作者:
    Victor J. Torres
Autophagy and microbial pathogenesis
自噬与微生物发病机制
  • DOI:
    10.1038/s41418-019-0481-8
  • 发表时间:
    2020-01-02
  • 期刊:
  • 影响因子:
    15.400
  • 作者:
    Matthew D. Keller;Victor J. Torres;Ken Cadwell
  • 通讯作者:
    Ken Cadwell
Modulation of emSalmonella/em virulence by a novel SPI-2 injectisome effector that interacts with the dystrophin-associated protein complex
一种与肌营养不良蛋白相关蛋白复合物相互作用的新型 SPI-2 注射体效应子对 emSalmonella/em 毒力的调节
  • DOI:
    10.1128/mbio.01128-24
  • 发表时间:
    2024-06-04
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Xiu-Jun Yu;Haixia Xie;Yan Li;Mei Liu;Ruhong Hou;Alexander V. Predeus;Blanca M. Perez Sepulveda;Jay C. D. Hinton;David W. Holden;Teresa L. M. Thurston;Victor J. Torres
  • 通讯作者:
    Victor J. Torres

Victor J. Torres的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Victor J. Torres', 18)}}的其他基金

Investigating the relationship between antibiotics and nosocomial pneumonia.
调查抗生素与院内肺炎的关系。
  • 批准号:
    10078595
  • 财政年份:
    2020
  • 资助金额:
    $ 25.43万
  • 项目类别:
Alternatively activated macrophages during helminth infection
蠕虫感染期间巨噬细胞的选择性激活
  • 批准号:
    10221497
  • 财政年份:
    2017
  • 资助金额:
    $ 25.43万
  • 项目类别:
Alternatively activated macrophages during helminth infection
蠕虫感染期间巨噬细胞的选择性激活
  • 批准号:
    9976440
  • 财政年份:
    2017
  • 资助金额:
    $ 25.43万
  • 项目类别:
Mechanistic Studies Of The Mode Of Action Of The Staphylococcus aureus LukAB Cyto
金黄色葡萄球菌 LukAB Cyto 作用方式的机制研究
  • 批准号:
    8670695
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Contribution of LukED to Staphylococcus aureus pathobiology
LukED 对金黄色葡萄球菌病理学的贡献
  • 批准号:
    10893253
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Contribution of LukED to Staphylococcus aureus pathobiology
LukED 对金黄色葡萄球菌病理学的贡献
  • 批准号:
    8774582
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Mechanistic Studies Of The Mode Of Action Of The Staphylococcus aureus LukAB Cyto
金黄色葡萄球菌 LukAB Cyto 作用方式的机制研究
  • 批准号:
    8437950
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Contribution of LukED to Staphylococcus aureus pathobiology
LukED 对金黄色葡萄球菌病理学的贡献
  • 批准号:
    9978683
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Contribution of LukED to Staphylococcus aureus pathobiology
LukED 对金黄色葡萄球菌病理学的贡献
  • 批准号:
    10214497
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Contribution of LukED to Staphylococcus aureus pathobiology
LukED 对金黄色葡萄球菌病理学的贡献
  • 批准号:
    8632282
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了